Max Robotics — Global Service Robot Directory + US Certification

About

Celso Granato is a clinical and diagnostic researcher whose work has made significant contributions to infectious disease detection, particularly in the context of the COVID-19 pandemic. His research focuses on mass spectrometry-based diagnostics, proteomics, and the development of rapid, scalable testing methodologies for viral pathogens. Granato's most influential contribution came in 2020 with the development of a high-throughput targeted proteomics assay capable of detecting SARS-CoV-2 nucleoprotein in large clinical sample cohorts — a landmark study that garnered 126 citations and addressed one of the most urgent public health challenges of our time. Recognizing that widespread testing was critical to pandemic control, his team demonstrated that mass spectrometry could serve as a fast and cost-effective alternative to conventional diagnostic approaches. His complementary work on tandem mass spectrometry further reinforced this methodology's clinical applicability, offering accessible solutions for laboratories with resource constraints. Granato's research stands at the intersection of clinical diagnostics and advanced analytical chemistry, providing the scientific community with innovative tools to respond rapidly to emerging infectious disease outbreaks.